22 May 2013
Keywords: serono, debuts, rebif, web, site, world, third-largest
Article | 27 June 2005
Serono, the world's third-largest biotechnology company, has launched a new web site for its multiple sclerosis drug Rebif (interferon beta-1 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.